Evidence map›Paper›PMID 39677066›Full record

ArticleCureus2024

Antibiotic Resistance, and Biofilm Forming Characteristics of Escherichia coli Clinical Isolates at a Hospital in Tigray, Northern Ethiopia.

Teklay Gebremariam, Tadesse Eguale, Tesfaye Belay, Alem A Kalayu, Teferra Abula, Ephrem Engidawork

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Teklay GebremariamDepartment of Pharmacology, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, ETH.
Tadesse EgualeMicrobiology Unit, Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, ETH.
Tesfaye BelayDepartment of Applied Sciences and Mathematics, School of Stem, Blue Field State College, Bluefield, USA.
Alem A KalayuDepartment of Microbiology, Immunology and Parasitology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, ETH.
Teferra AbulaDepartment of Pharmacology, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, ETH.
Ephrem EngidaworkDepartment of Pharmacology, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, ETH.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodFrom patients exhibiting signs of bacterial infection, while excluding recent antibiotic users or those with incomplete data, 417 clinical samples comprised of 84 blood, 108 pus, and 225 urine samples were obtained in a cross-sectional study. The combination disc method was used to test extended-spectrum beta-lactamase (ESBL) production, and Ampicillin C (AmpC) enzyme presence was confirmed with cefoxitin and cefotaxime discs. Data analysis was conducted with SPSS version 22 software, applying ANOVA and logistic regression, with significance set at p<0.05.

resultAmong the 417 samples, 109 (26.1%) tested positive for

conclusionIn northern Ethiopia,

Indexed as

ampicillinc beta-lactamasebiofilmescherichia coliextended-spectrum beta-lactamasetissue culture plate method

Identifiers

PMID39677066
PMCPMC11645175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.